SR-46349 hemifumarate salt
SIGMA/S7201 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 130580-02-8
Empirical Formula (Hill Notation): C19H21FN2O2 · 0.5 C4H4O4
Molecular Weight: 386.42
MDL Number: MFCD12546335
Linear Formula: C19H21FN2O2 · 0.5 C4H4O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/2C19H21FN2O2.C4H4O4/c2 |
| InChI key | RNLKLYQQDLHHBH-ABDBJYMXSA |
| originator | Sanofi Aventis |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)C=CC(O)=O.CN(C)CC |
| solubility | DMSO: ≥10 mg/mL |
| storage condition | protect from light |
| storage temp. | 2-8°C |
| Application: | SR-46349 hemifumarate salt may be used in cell signaling studies. |
| Biochem/physiol Actions: | ASTAR (Antagonist of Serotonin 5HT2A Receptors). |
| Biochem/physiol Actions: | SR-46349 is an antagonist of 5-HT (2A/2C) receptor and increases the release of dopamine by medial prefrontal cortex in rats.1 It increases the signal transduction induced by 5-HT2 receptor by binding with high affinity.2 SR-46349 inhibits the aggregation of rabbit and human platelets in response to serotonin.3 |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 - H410 |
| Precautionary statements | P273 - P501 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-50 |
| Safety Statements | 61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



